Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27637888)

Published in Clin Cancer Res on September 16, 2016

Authors

Yi Zhong1, Anne Macgregor-Das2,3, Tyler Saunders2, Martin C Whittle4, Alvin Makohon-Moore1,2,3, Zachary A Kohutek5, Justin Poling2, Brian T Herbst1, Breanna M Javier1, Leslie Cope6, Steven D Leach1,7,8, Sunil R Hingorani4,9, Christine A Iacobuzio-Donahue10,8,11

Author Affiliations

1: The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
2: Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.
3: Graduate Program in Pathobiology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.
4: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
5: Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
6: Department of Oncology Biostatistics, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.
7: Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
8: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
9: Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington.
10: The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York. iacobuzc@mskcc.org.
11: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles cited by this

Surfing the p53 network. Nature (2000) 35.36

Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48

Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85

Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell (2005) 14.21

Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17

Making sense of latent TGFbeta activation. J Cell Sci (2003) 8.90

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res (2014) 7.15

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol (2009) 6.43

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell (2009) 6.03

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell (2014) 5.87

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell (2014) 5.38

Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol (2010) 5.07

Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol (2015) 4.08

Whole genomes redefine the mutational landscape of pancreatic cancer. Nature (2015) 4.01

Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell (2003) 3.45

Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer (2014) 3.37

Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther (2005) 3.28

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22

Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev (2006) 3.16

Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci U S A (2009) 3.08

Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science (2007) 2.97

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell (2007) 2.36

The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med (2009) 2.16

RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell (2015) 1.80

Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79

Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ (2013) 1.77

Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol (2011) 1.75

Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. Science (2007) 1.65

Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res (2012) 1.37

Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol (1994) 1.35

Evolution and dynamics of pancreatic cancer progression. Oncogene (2013) 1.25

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer. Oncotarget (2014) 1.14

Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg (2011) 1.07

Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res (2011) 1.07

Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discov (2015) 0.94

Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol (2014) 0.86

NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells. J Clin Endocrinol Metab (2012) 0.86